Adamas already got good Phases III data, but they have follow on data for 2 years. they already have a pdufa in august. argunment seems to be that they didnt invent adamantine, just modified delivery
saw something about igalen being off to a good start revenue wise. good luck this week
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links